Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.
Theravance Biopharma, Inc. net margin for the quarter ending 2026-06-30 was -28.45%, a 113.59% decline year-over-year.
Theravance Biopharma, Inc. net margin for the quarter ending 2026-03-31 was -27.87%, a change of 60.37% year-over-year.
Theravance Biopharma, Inc. net margin for the quarter ending 2025-12-31 was 132.98%, a change of 215.77% year-over-year.
Theravance Biopharma, Inc. net margin for the quarter ending 2025-09-30 was 18.08%, a change of 93.36% year-over-year.
Theravance Biopharma, Inc. net margin for fiscal 2025 was 98.54%, a change of 186.17% from fiscal 2024.
Theravance Biopharma, Inc. net margin for fiscal 2024 was -87.63%, a change of 8.48% from fiscal 2023.
Theravance Biopharma, Inc. net margin for fiscal 2023 was -96.11%, a 105.66% decline from fiscal 2022.
Theravance Biopharma, Inc. net margin for fiscal 2022 was 1698.54%, a change of 2059.09% from fiscal 2021.